Abstract:OBJECTIVE:To investigate the expression of aldehyde dehydrogenase 3B1 (ALDH3B1) in gastric cancer and explore its correlation with the pathological parameters and long-term prognosis of the patients.METHODS:We analyzed the clinical data of 101 patients who underwent radical gastrectomy for gastric cancer in our hospital between January, 2013 and November, 2016, and examined the expression of ALDH3B1 in paraffin-embedded samples of gastric cancer tissues and adjacent tissues from these cases by immunohistochemical staining. We evaluated the correlation between ALDH3B1 expressions and histopathological parameters and assessed the predictive value of ALDH3B1 expression for long-term survival of the patients. We also examined the effect of lentivirus-mediated interference and overexpression of ALDH3B1 on the malignant behaviors of MGC-803 gastric cancer cells.RESULTS:The expressions of ALDH3B1 and Ki67 were significantly higher in gastric cancer tissues than in adjacent tissues (P < 0.05). In gastric cancer patients, ALDH3B1 expression was positively correlated with peripheral blood CEA and CA19-9 levels (P < 0.01). The proportion of patients with CEA ≥5 μg/L, CA19-9 ≥37 kU/L, T stage of 3- 4, and N stage of 2-3 was significantly greater in high ALDH3B1 expression group than in low expression group. Kaplan-Meier survival analysis showed that the 5-year survival rate was significantly lower in gastric cancer patients with high ALDH3B1 expressions (P < 0.01). Univariate and Cox multiple regression analyses identified a high expression of ALDH3B1 (P < 0.05, HR= 0.231, 95% CI: 0.064-0.826), CEA≥5 μg/L (P < 0.01, HR=4.478, 95% CI: 1.530-13.110), CA19-9≥37 kU/L (P < 0.01, HR=3.877, 95% CI: 1.625-9.247), T stage of 3-4 (P < 0.01, HR=4.953, 95% CI: 1.768-13.880), and N stage of 2-3 (P < 0.05, HR=2.152, 95% CI: 1.152-4.022) as independent risk factors affecting 5-year survival after radical gastrectomy. The relative ALDH3B1 expression level, at the cut-off point of 4.66, showed a sensitivity of 76.47% and a specificity of 76% for predicting 5-year postoperative death (P < 0.01). In the cell experiment, overexpression of ALDH3B1 obviously promoted the proliferation, migration and invasion of MGC-803 cells.CONCLUSION:As an independent risk factor affecting 5-year survival after radical gastrectomy, ALDH3B1 is highly expressed in gastric cancer and correlated with pathological parameters of the tumor, and a high ALDH3B1 expression may promote proliferation, invasion and metastasis of gastric cancer cells.

Identification of Musashi-1 and ALDH1 As Carcinogenesis, Progression, and Poor-Prognosis Related Biomarkers for Gallbladder Adenocarcinoma

Positive ALDH1A3 and Negative GPX3 Expressions Are Biomarkers for Poor Prognosis of Gallbladder Cancer

196P Expression of Musashi-1 Protein and Its Implications in Progression and Prognosis of Gastric Cancer

Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression

Identification of Cd146 Expression, Angiogenesis, and Lymphangiogenesis As Progression, Metastasis, and Poor-Prognosis Related Markers for Gallbladder Adenocarcinoma

Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma.

MCM2 and TIP30 Are Prognostic Markers in Squamous Cell/adenosquamous Carcinoma and Adenocarcinoma of the Gallbladder

Expression of ABCG2, SFRP2, BRMS1 and HPA in Benign and Malignant Lesions of the Gallbladder and Their Clinicopathological Significances

ILK and PRDX1 Are Prognostic Markers in Squamous Cell/adenosquamous Carcinomas and Adenocarcinoma of Gallbladder

ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer

Expression of HMGA2 and CD9 and Their Clinicopathological Significances in Benign and Malignant Lesions of Gallbladder

Expression of MK-1 and RegⅣ and its clinicopathological significances in the benign and malignant lesions of gallbladder

Clinicopathologic Significance of Minichromosome Maintenance Protein 2 and Tat-interacting Protein 30 Expression in Benign and Malignant Lesions of the Gallbladder

ALDH3B1 Expression is Correlated with Histopathology and Long-Term Prognosis of Gastric Cancer

Expression of Cdx2 and Hepatocyte Antigen in Benign and Malignant Lesions of Gallbladder and Its Correlation with Histopathologic Type and Clinical Outcome

Nectin-2 and DDX3 Are Biomarkers for Metastasis and Poor Prognosis of Squamous Cell/adenosquamous Carcinomas and Adenocarcinoma of Gallbladder.

The Clinical Significance of MGMT, Hmlh1 and Hmsh2 Gene Expressions in Gallbladder Adenocarcinoma and Adjacent Tissues

Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas of the Gallbladder: an Immunohistochemistry Study of Prognostic Markers

Value of CagA, HER2, ALDH1, and KiSS-1 in Predicting Metastasis and Prognosis for Gastric Adenocarcinoma.

Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder

Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance